Medical News

RSS

MedCath to sell Texsan Heart Hospital

MedCath Corporation announced today it has entered into a definitive agreement to sell substantially all the assets of Texsan Heart Hospital, owned by MedCath and its physician investors, to Methodist Healthcare System of San Antonio. The transaction is expected to close during MedCath's second fiscal quarter of 2011, which ends March 31, subject to regulatory approval and customary closing conditions.

8 Nov 2010

Guided Therapeutics receives $244,479 federal grant to advance LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it received a $244,479 Federal grant to advance its LightTouch™ Cervical Scanner, currently under FDA review for market approval.

8 Nov 2010

GRS and CORRONA enter strategic partnership for clinical research in rheumatoid arthritis

Global Research Services, LLC (GRS), an international full-service clinical research organization (CRO), and The Consortium of Rheumatology Researchers of North America, Inc. (CORRONA), the largest independent initiative for clinical research in rheumatoid arthritis, announced today their strategic partnership to bring together Phase I-IV clinical research capabilities with the largest rheumatology patient registry in North America.

8 Nov 2010

Gentium third quarter total revenues increase to EUR 5.91 million

Gentium S.p.A. today reported financial results for the quarter ended September 30, 2010. The Company reports its financial condition and operating results using U.S. Generally Accepted Accounting Principles (GAAP). The Company's financial statements are prepared using the Euro as its functional currency.

8 Nov 2010

First Edition: November 8, 2010

Today's health policy headlines include more post-mortem reports about the health law's impact on the election.

8 Nov 2010

Spaceflights negatively impact bone health

Long-duration spaceflight may have a long-term negative impact on bone health, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

8 Nov 2010

Structural deformities affect typing styles of touch typists with rheumatoid arthritis

Joint damage caused by rheumatoid arthritis can lead to difficulties in typing and can force people to seek alternative—but potentially more destructive—ways of putting their fingers to the keyboard, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

8 Nov 2010

Solutia sells Perkalink business

Solutia Inc. announced today that it has sold its Perkalink® business and entered into a definitive agreement to sell select Primary Accelerators assets to LANXESS, a Germany-based specialty chemicals company.

8 Nov 2010

Gents renews distribution agreement for AcnEase with Herborium

Herborium Group, Inc., a Botanical Therapeutics™ company, during its shareholder conference call yesterday afternoon, announced that Gents, AB of Helsingborg, Sweden, renewed its distribution agreement to supply AcnEase® throughout Sweden.

8 Nov 2010

Apples lower risk for developing heart disease

Recent research out of the University of Michigan Health System – a premier academic medical center – has found that adding more apples and apple products to your diet may be an easy way to lower your risk for developing heart disease. More than one in three U.S. adults has one or more types of cardiovascular disease (CVD) according to the American Heart Association. Heart disease is the leading cause of death in the United States.

8 Nov 2010

Community Health Systems amends existing credit agreement with subsidiary

Community Health Systems, Inc. today announced that on November 5, 2010, it and its wholly-owned subsidiary CHS/Community Health Systems, Inc. entered into an amendment and restatement (the "Amendment") of their existing credit agreement, dated as of July 25, 2007 (as amended and restated, the "Credit Agreement").

8 Nov 2010

Cadence offers $85 million shares of common stock in public offering

Cadence Pharmaceuticals, Inc. today announced that it is offering to sell $85 million worth of shares of its common stock in an underwritten public offering.

8 Nov 2010

U.N. Human Development Report finds significant quality of life gains among many developing countries over last 40 years, but gaps persist

"People around the globe are healthier, richer and better educated than ever before, with most developing countries registering huge gains over the last 40 years, a U.N. report [.pdf] released Thursday shows," the Canadian Press reports.

8 Nov 2010

TransTech Pharma, High Point receive $1.96 million grants under QTDP program

TransTech Pharma, Inc. and High Point Pharmaceuticals, LLC. today announced that they have been awarded cash grants totaling $1.96 million under the U.S. Government's Qualifying Therapeutic Discovery Project program.

8 Nov 2010

West Hertfordshire Hospitals NHS Trust selects Carefx Fusionfx clinical portal

Carefx Corp., a leading provider of interoperable workflow solutions, today announced that West Hertfordshire Hospitals NHS Trust (West Herts) has chosen the Fusionfx solution suite to provide simplified access to an aggregate view of patient information within a singular portal. The portal is a component of the Trust's strategy to "Connect All," rather than "Replace All."

8 Nov 2010

Chindex 2011 second quarter revenue increases 18.6% to $45.2 million

Chindex International, Inc. a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the second quarter and first half of fiscal year 2011, which ended September 30, 2010.

8 Nov 2010

Santarus's budesonide MMX drug shows positive result for active ulcerative colitis

Santarus, Inc. a specialty biopharmaceutical company, today announced positive top-line results from a second Phase III clinical study evaluating the safety and efficacy of budesonide MMX for the induction of remission of mild or moderate active ulcerative colitis.

8 Nov 2010

XenoPort third quarter net loss decreases to $19.9 million

XenoPort, Inc. announced today financial results for the third quarter and nine months ended September 30, 2010. Revenues for the third quarter were $0.4 million, compared to $0.4 million for the same period in 2009. Net loss for the third quarter was $19.9 million, compared to a net loss of $24.4 million for the same period in 2009.

8 Nov 2010

Officials discuss HIV/AIDS in Caribbean during PANCAP meeting

"Despite the gains associated with antiretroviral treatments (ART) over the last decade, HIV/AIDS remains the leading cause of death among young and middle-aged adults in the Caribbean, warns a new U.N. report" that was released during the 10th Annual General Meeting of the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) that concluded on Tuesday, Inter Press Service reports (Richards, 11/3).

8 Nov 2010

China Kanghui third quarter net revenue increases 33.9% to RMB63.6 million

China Kanghui Holdings a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced financial results for the third quarter of 2010.

8 Nov 2010